GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Biostem Technologies BSEM · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.71

-13.53%

Close of 19 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Biostem Technologies — daily BSEM Delayed
Market value
$15.4m
Last close × shares
Volume
324k
Shares, 19 Nov 2026
Price to earnings
0.7

About Biostem Technologies

Its shares trade under the ticker BSEM. It has been listed since 11 July 2001. In the fiscal year to 31 December 2024, it reported revenue of $301.8m and net income of $31.9m. At that date it held total assets of $140.4m and shareholders' equity of $40.9m.

BioStem Technologies, Inc. engages in the provision of regenerative medicine and anti-aging solutions. The company is headquartered in Pompano Beach, Florida. The company went IPO on 2001-07-11. The firm is a biotechnology company focused on the development of anti-aging nutraceutical and cosmeceutical products, stem cell therapies, pharmaceuticals and educational provider of cell treatment protocols. The firm's divisions include Biostem Cell Therapy, Biostem Pharmaceuticals and Biostem Wellness. Biostem Cell Therapy provides stem cell therapies, stem cell banking, stem cell therapy, and stem cell research and development. Biostem Pharmaceuticals provides research and product development, active pharmaceutical ingredient (API) re-packaging and lab services. Biostem Wellness provides anti-aging and rejuvenation products and services, wellness and management programs, among others. The firm's subsidiaries include Biostem Wellness, Inc., Biostem Pharmaceuticals, Inc., Biostem Cell Therapy, Inc., Biostem International Inc. and Biostem Helps, Inc.

Figures and description from our data supplier, not checked against the company's own report.

More about Biostem Technologies →

Latest on Biostem Technologies

Our reporting

We have not reported on Biostem Technologies yet.

Next results

23 Mar 2027

Due on 23 Mar 2027. Analysts expect earnings of -0.45 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Biostem Technologies's ticker?

Biostem Technologies trades as BSEM on its US listing, under ISIN US0906842002.

What was Biostem Technologies's last closing price?

0.71 on 19 Nov 2026. The figure is in USD and is never converted.

When does Biostem Technologies next report results?

Results are expected on 12 Nov 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.